Free Trial

Stevanato Group (STVN) Stock Forecast & Price Target

Stevanato Group logo
€20.56 -0.78 (-3.66%)
(As of 12/20/2024 08:57 PM ET)

Stevanato Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
5

Based on 6 Wall Street analysts who have issued ratings for Stevanato Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a hold rating, and 5 have given a buy rating for STVN.

Consensus Price Target

N/A

Get the Latest News and Ratings for STVN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Stevanato Group and its competitors.

Sign Up

STVN Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

STVN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STVN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Stevanato Group Stock vs. The Competition

TypeStevanato GroupMedical Companies
Consensus Rating Score
2.83
2.81
Consensus RatingModerate BuyModerate Buy
News Sentiment Rating
Neutral News

See Recent STVN News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/13/2024Bank of America
3 of 5 stars
 Boost TargetBuy ➝ Buy$24.00 ➝ $26.00
12/13/2024Wolfe Research
3 of 5 stars
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$28.00
12/3/2024Morgan Stanley
3 of 5 stars
 Reiterated RatingEqual Weight$24.00 ➝ $23.00
8/7/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$30.00 ➝ $28.00
4/22/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
3/25/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$38.00
11/1/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$39.00 ➝ $29.00
9/19/2023CJS Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$36.00
8/30/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$35.00 ➝ $37.00
7/31/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$30.00 ➝ $35.00
5/5/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$28.00 ➝ $29.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:14 AM ET.


STVN Forecast - Frequently Asked Questions

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stevanato Group in the last year. There is currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STVN shares.

According to analysts, Stevanato Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Stevanato Group has been rated by research analysts at Bank of America, Morgan Stanley, and Wolfe Research in the past 90 days.

Analysts like Stevanato Group more than other "medical" companies. The consensus rating score for Stevanato Group is 2.83 while the average consensus rating score for "medical" companies is 2.81. Learn more on how STVN compares to other companies.


This page (NYSE:STVN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners